ACAT1 regulates the dynamics of free cholesterols in plasma membrane which leads to the APP-α-processing alteration.

ACAT1 regulates the dynamics of free cholesterols in plasma membrane which leads to the APP-α-processing alteration.
复制标题

DOI:
10.1093/abbs/gmv101
复制
发表时间:
2015-12
影响因子:
3.7
通讯作者:
M. Zhu;Xiaonan Zhao;Jia Chen;Jiajia Xu;Guangjing Hu;Dongqing Guo;Qin Li;Xiaowei Zhang;C. Chang;B. Song;Ying Xiong;Ta-Yuan Chang;Bo-Liang Li
M. Zhu;Xiaonan Zhao;Jia Chen;Jiajia Xu;Guangjing Hu;Dongqing Guo;Qin Li;Xiaowei Zhang;C. Chang;B. Song;Ying Xiong;Ta-Yuan Chang;Bo-Liang Li
中科院分区:
生物学3区
文献类型:
--
作者:
M. Zhu;Xiaonan Zhao;Jia Chen;Jiajia Xu;Guangjing Hu;Dongqing Guo;Qin Li;Xiaowei Zhang;C. Chang;B. Song;Ying Xiong;Ta-Yuan Chang;Bo-Liang Li

文献摘要

相似文献

酰辅酶A:胆固醇酰基转移酶1(ACAT1)是细胞内唯一以游离胆固醇为底物的关键酶,参与细胞内胆固醇的稳态。在本研究中,我们以人神经母细胞瘤细胞系SK-N-SH为模型,首次观察到抑制ACAT1可以减少淀粉样前体蛋白(APP)的α加工。同时,用ACAT1的小干扰RNA和表达载体进行的转染实验表明,ACAT1可以依赖地影响APP-α的加工。此外,抑制ACAT1可以增加质膜中的游离胆固醇(PM-FC),并且抑制ACAT1导致的PM-FC的增加可以导致APP-α加工的减少,这表明ACAT1调节PM-FC的动力学,从而导致APP-α加工的改变。更重要的是,进一步的结果表明,在ACAT1抑制下,PM-Fc和随后的APP-α-加工的变化不依赖于细胞总胆固醇水平,证实了ACAT1调节PM-Fc的动力学。最后,我们发现,即使当Niemann-Pick-C型依赖途径被阻断时,ACAT1抑制仍然明显导致PM-FC增加,表明ACAT1依赖的途径负责PM-FC向细胞内池的穿梭。我们的数据提供了一种新的见解,即ACAT1可能在人神经细胞中发挥重要作用,它在酶促调节PM-Fc的动态过程中可能发挥着重要作用。
Acyl-CoA:cholesterol acyltransferase 1 (ACAT1) is a key enzyme exclusively using free cholesterols as the substrates in cell and is involved in the cellular cholesterol homeostasis. In this study, we used human neuroblastoma cell line SK-N-SH as a model and first observed that inhibiting ACAT1 can decrease the amyloid precursor protein (APP)-α-processing. Meanwhile, the transfection experiments using the small interfering RNA and expression plasmid of ACAT1 indicated that ACAT1 can dependently affect the APP-α-processing. Furthermore, inhibiting ACAT1 was found to increase the free cholesterols in plasma membrane (PM-FC), and the increased PM-FC caused by inhibiting ACAT1 can lead to the decrease of the APP-α-processing, indicating that ACAT1 regulates the dynamics of PM-FC, which leads to the alteration of the APP-α-processing. More importantly, further results showed that under the ACAT1 inhibition, the alterations of the PM-FC and the subsequent APP-α-processing are not dependent on the cellular total cholesterol level, confirming that ACAT1 regulates the dynamics of PM-FC. Finally, we revealed that even when the Niemann-Pick-Type C-dependent pathway is blocked, the ACAT1 inhibition still obviously results in the PM-FC increase, suggesting that the ACAT1-dependent pathway is responsible for the shuttling of PM-FC to the intracellular pool. Our data provide a novel insight that ACAT1 which enzymatically regulates the dynamics of PM-FC may play important roles in the human neuronal cells.